Thomas A Mavrakanas

8PUBLICATIONS
17CO-AUTHORS
Molecular targetsRural clinical healthCardiovascular medicine and haematology not elsewhere classifiedEpidemiological modellingCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 31, 2026
The Effect of Canagliflozin Dose on Renal and Cardiovascular Outcomes in Type 2 Diabetes and High Cardiovascular Risk.

|Jun 04, 2024
Utilizing synchronous care to improve cardiovascular and renal health among patients with type 2 diabetes: Proof-of-concept results from the DECIDE-CV clinical programme.

Pedro Marques, Thomas A Mavrakanas, Julian Guida

|Dec 14, 2022
Apixaban versus No Anticoagulation by P2Y12 Inhibitor Prescription Status in Dialysis Patients with Atrial Fibrillation.

Thomas A Mavrakanas, David M Charytan

|May 16, 2022
Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Amir Razaghizad, Emily Oulousian, Varinder Kaur Randhawa

|Jun 08, 2021
Epidemiology, thrombolytic management, and outcomes of acute stroke among patients with chronic kidney disease: a systematic review and meta-analysis.

Ido Zamberg, Marie Assouline-Reinmann, Emmanuel Carrera

|Jul 13, 2018
Echocardiographic parameters and renal outcomes in patients with preserved renal function, and mild- moderate CKD.

Thomas A Mavrakanas, Aisha Khattak, Karandeep Singh

Pageof 2

Frequent Collaborators

3 joint publications

Abhinav Sharma

2 joint publications

Michael A Tsoukas

1 joint publications

Jean-Luc Reny

1 joint publications

Pierre Fontana